ZOLL Respicardia, Inc.
United States US-MF-000023953 Last updated 8 Jun 2026
- Devices
- 13
- Registries
- EUDAMEDGUDIDFDA 510(k)
- FDA recalls
- 0
Catalogue
remede Ref 1004A-F
remede System Ref 1001
VANES Delivery System (VDS) Ref K260459
remede Ref 1004A
Respiguide Delivery System Ref 7120-K
remede Ref 1006
remedē Respistim Ref 4065
remedē Respistim Ref 3103
remedē Respistim Ref 3201
Respiguide Delivery System Ref 7000-K
remedē Respistim Ref 3102
remede System Ref 1002A
remede Respistim Ref 3101
Related companies
Authorised representatives
About
remedē®, an implantable therapy that activates automatically to treat the harmful effects of central sleep apnea (CSA)
Information
- Country
- United States
- Address
- 12400, Whitewater Drive, Minnetonka, United States
- Website
- remede.zoll.com
- facebook.com/remedesystem
- [email protected]
- Phone
- + 1 351 500 4934
- PRRC contact
- Jessica DeMarte
- EUDAMED SRN
- US-MF-000023953